HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen Day Selected Research

MK-0952

11/2010Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen Day Research Topics

Disease

1Alzheimer Disease (Alzheimer's Disease)
01/2016
1Osteoporosis
06/2011
1Cognitive Dysfunction
11/2010
1Chronic Obstructive Pulmonary Disease (COPD)
06/2006
1Asthma (Bronchial Asthma)
06/2006
1T-Cell Leukemia (Leukemia, T Cell)
01/2003

Drug/Important Bio-Agent (IBA)

2Phosphodiesterase 4 InhibitorsIBA
11/2010 - 06/2006
1Peptide Elongation Factors (Elongation Factor)IBA
01/2016
1odanacatibIBA
06/2011
1MK-0952IBA
11/2010
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
11/2010
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
06/2006
1L-454,560IBA
06/2006
1Triglycerides (Triacylglycerol)IBA
01/2003
1Hemoglobins (Hemoglobin)IBA
01/2003
1Edetic Acid (EDTA)FDA Link
01/2003
1BilirubinIBA
01/2003
1acid citrate dextroseIBA
01/2003
1AnticoagulantsIBA
01/2003

Therapy/Procedure

1Therapeutics
06/2011